Clinical Trial Update: Hyperthermic Intraperitoneal Chemotherapy Trial Comparing Quality of Life in Patients With Stage IIIC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating quality of life after hyperthermic intraperitoneal chemotherapy in advanced ovarian, fallopian tube, and primary peritoneal cancers has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Hyperthermic intraperitoneal chemotherapy (HIPEC)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Cancer | Phase 2 | Status: COMPLETED | Results posted: 2025-10-21